Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8,465 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and efficacy of PD-1/PD-L1 blockade in patients with preexisting antinuclear antibodies.
Sakakida T, Ishikawa T, Chihara Y, Harita S, Uchino J, Tabuchi Y, Komori S, Asai J, Narukawa T, Arai A, Tsunezuka H, Kosuga T, Konishi H, Moriguchi M, Yasuda H, Hongo F, Inoue M, Hirano S, Ukimura O, Itoh Y, Taguchi T, Takayama K. Sakakida T, et al. Among authors: inoue m. Clin Transl Oncol. 2020 Jun;22(6):919-927. doi: 10.1007/s12094-019-02214-8. Epub 2019 Oct 1. Clin Transl Oncol. 2020. PMID: 31576495
Characterization of membrane-bound serine protease related to degradation of oxidatively damaged erythrocyte membrane proteins.
Fujino T, Ishikawa T, Inoue M, Beppu M, Kikugawa K. Fujino T, et al. Among authors: inoue m. Biochim Biophys Acta. 1998 Sep 23;1374(1-2):47-55. doi: 10.1016/s0005-2736(98)00131-x. Biochim Biophys Acta. 1998. PMID: 9814851 Free article.
It has been shown that erythrocyte membrane proteins become susceptible to degradation by membrane-bound serine protease activity after oxidative modification of the membranes (M. Beppu, M. Inoue, T. Ishikawa, K. Kikugawa, Biochim. Biophys. ...
It has been shown that erythrocyte membrane proteins become susceptible to degradation by membrane-bound serine protease activity after oxid …
Exploring the Limits of Endovascular Therapy for Large Core Patients: Where Do We Need More Data?
Albers GW, Heit JJ, Lansberg MG, Inoue M, Huo X, Yedavalli VS, Seners P, McCullough-Hicks M, Cereda CW, Tsai JP, Mistry EA, Chatterjee AR, Derdeyn CP, Khatri P, Olivot JM, Hill MD, Saver JL, Fisher M. Albers GW, et al. Among authors: inoue m. Stroke. 2024 Jun 5. doi: 10.1161/STROKEAHA.124.047228. Online ahead of print. Stroke. 2024. PMID: 38836345 No abstract available.
Gustave Roussy Immune score as a prognostic biomarker in patients with platinum-refractory metastatic urothelial carcinoma treated with pembrolizumab: YUSHIMA study.
Tanabe K, Kobayashi S, Maezawa Y, Ishihara K, Inoue N, Izumi K, Fujiwara M, Toide M, Yamamoto T, Uehara S, Araki S, Inoue M, Takazawa R, Numao N, Ohtsuka Y, Tanaka H, Yoshida S, Fujii Y. Tanabe K, et al. Among authors: inoue m. Int J Clin Oncol. 2024 Jun 4. doi: 10.1007/s10147-024-02563-7. Online ahead of print. Int J Clin Oncol. 2024. PMID: 38833113
8,465 results